SAN JOSE, Calif. — January 28, 2026 — Leads & Copy — Rani Therapeutics Holdings, Inc. (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, has announced the promotion of Alireza Javadi, Ph.D., to Chief Technical Officer.
According to Talat Imran, Chief Executive Officer of Rani Therapeutics, Alireza’s technical and operational leadership experience in the medical device and life science industries will be instrumental in scaling the company’s supply chain and manufacturing capabilities as it continues to advance its pipeline. Imran noted the promotion comes during “an exciting era” for Rani, as evidenced by the company’s collaboration with Chugai and its newly initiated Phase 1 study of RT-114 for the treatment of obesity.
In his previous role at Rani, Alireza served as Vice President, Technical Operations, where he was responsible for Rani’s R&D, manufacturing, and automation teams. In his expanded role as Chief Technical Officer, he will continue to lead these core functions while also assuming responsibility for quality assurance.
Prior to joining Rani in 2022, Alireza spent five years as Director of Operations at Cretex Medical. Before Cretex, Alireza’s prior roles include Tooling and Engineering Manager at JunoPacific, Senior Process Development Engineer at G&W Electric Co., and Principal Scientist at the Wisconsin Institute for Discovery. He holds a Ph.D. in Materials Science from University of Wisconsin and a Master’s degree in Advanced Engineering Materials from Chalmers University in Sweden.
Rani Therapeutics is focused on advancing technologies to enable the development of orally administered biologics and drugs. Rani has developed the RaniPill® capsule, a novel, proprietary and patented platform technology intended to replace subcutaneous injection or intravenous infusion of biologics and drugs with oral dosing. Rani has successfully conducted several preclinical and clinical studies to evaluate safety, tolerability and bioavailability using RaniPill® capsule technology.
Source: Rani Therapeutics
